placebo sitagliptin

DRUG2 trials

Sponsors

GlaxoSmithKline, Eurofarma Laboratorios S.A.

Conditions

Diabetes Mellitus, Type 2

Phase 2

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

CompletedNCT02689362

Eurofarma Laboratorios S.A.Diabetes Mellitus, Type 2

Start: 2017-08-08End: 2018-08-09Updated: 2018-08-14

Phase 3

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

CompletedNCT00838903

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2009-02-28End: 2013-04-30Updated: 2017-01-09

Related Papers

Efficacy and safety of evogliptin in the treatment of type 2 diabetes mellitus in a Brazilian population: a randomized bridging study.

2019-12-195 citations

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy.

2017-06-1528 citations

Wirksamkeit und Sicherheit von Albiglutid bei Metformin-behandelten Patienten mit Typ 2 Diabetes: Ergebnisse der HARMONY 3 Studie

Diabetologie und Stoffwechsel2014-05-06

Albiglutide Superior to Sitagliptin and Glimepiride in T2DM

MD Conference Express2013-11-01